MAB10234
Anti-Hepatitis B Virus Surface Antigen Antibody, clone H21F8-1
ascites fluid, clone H21F8-1, Chemicon®
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41
Recommended Products
biological source
mouse
Quality Level
antibody form
ascites fluid
antibody product type
primary antibodies
clone
H21F8-1, monoclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
immunofluorescence: suitable
isotype
IgM
shipped in
wet ice
General description
Hepatitis B virus surface antigen is one of the earliest markers of infection with hepatitis B virus. Hepatitis B virus surface antigen is tested for in the differential diagnosis of hepatitis. It is the first detectable viral antigen to appear during infection with this virus; however, early in an infection, this antigen may not be present and it may be undetectable later in the infection as it is being cleared by the host.
Application
Anti-Hepatitis B Virus Surface Antigen Antibody, clone H21F8-1 detects level of Hepatitis B Virus Surface Antigen & has been published & validated for use in IF.
Storage and Stability
Stable for 12 months when stored at -20°C from date of shipment
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Not finding the right product?
Try our Product Selector Tool.
Storage Class Code
10 - Combustible liquids
WGK
WGK 1
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Sang Hyun Nam et al.
Archives of pharmacal research, 29(11), 1042-1048 (2006-12-07)
Plasmid DNA vaccines encoding the hepatitis B virus (HBV) surface and hepatitis C virus (HCV) envelope antigens, respectively, were constructed, and attempt were made to find the possibility of a divalent vaccine against HBV and HCV. The expression of each
Clinical Characteristics and Surgical Outcome in Hepatocellular Carcinoma without Hepatitis B Virus Surface Antigen or Hepatitis C Virus Antibody
Tanaka, Kuniya, et al
Annals of Surgical Oncology, [Epub ahead of print]-[Epub ahead of print] (2006)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service